Exodus Point Capital Management, LP Pliant Therapeutics, Inc. Transaction History
Exodus Point Capital Management, LP
- $13.1 Billion
- Q1 2024
A detailed history of Exodus Point Capital Management, LP transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 77,576 shares of PLRX stock, worth $816,099. This represents 0.01% of its overall portfolio holdings.
Number of Shares
77,576
Previous 27,122
186.03%
Holding current value
$816,099
Previous $470,000
145.96%
% of portfolio
0.01%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding PLRX
# of Institutions
148Shares Held
63.8MCall Options Held
417KPut Options Held
123K-
Deep Track Capital, LP Greenwich, CT5.75MShares$60.5 Million2.83% of portfolio
-
Black Rock Inc. New York, NY4.66MShares$49 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.96MShares$41.6 Million0.01% of portfolio
-
First Light Asset Management, LLC Edina, MN3.53MShares$37.2 Million4.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.48MShares$36.6 Million0.0% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $512M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...